Jing Li

J. Zhao, J. Li, M. Chen et al.

Functional Data Analysis (FDA) is a statistical domain developed to handle functional data characterized by high dimensionality and complex data structures. Sequential Neural Networks (SNNs) are specialized neural networks capable of processing sequence data, a fundamental aspect of functional data. Despite their great flexibility in modeling functional data, SNNs have been inadequately employed in the FDA community. One notable advantage of SNNs is the ease of implementation, making them accessible to a broad audience beyond academia. Conversely, FDA-based methodologies present challenges, particularly for practitioners outside the field, due to their intricate complexity. In light of this, we propose utilizing SNNs in FDA applications and demonstrate their effectiveness through comparative analyses against popular FDA regression models based on numerical experiments and real-world data analysis. SNN architectures allow us to surpass the limitations of traditional FDA methods, offering scalability, flexibility, and improved analytical performance. Our findings highlight the potential of SNN-based methodologies as powerful tools for data applications involving functional data.

Dafei Yin, Jing Li, Gaosheng Wu

Predicting the success of startup companies is of great importance for both startup companies and investors. It is difficult due to the lack of available data and appropriate general methods. With data platforms like Crunchbase aggregating the information of startup companies, it is possible to predict with machine learning algorithms. Existing research suffers from the data sparsity problem as most early-stage startup companies do not have much data available to the public. We try to leverage the recent algorithms to solve this problem. We investigate several machine learning algorithms with a large dataset from Crunchbase. The results suggest that LightGBM and XGBoost perform best and achieve 53.03% and 52.96% F1 scores. We interpret the predictions from the perspective of feature contribution. We construct portfolios based on the models and achieve high success rates. These findings have substantial implications on how machine learning methods can help startup companies and investors.